Follow The Filings

LYELLyell Immunopharma Inc.

Q3 2025 13F holders among managers we track Latest ownership dossier

Ticker
LYEL
Type
Equity
Class
COM NEW
Total reported value (long equity)
Manager Report date Value Shares